Antinuclear antibodies directed to a 200-kilodalton polypeptide of the nuclear envelope in primary biliary cirrhosis. A clinical and immunological study of a series of 150 patients with primary biliary cirrhosis.
Antinuclear antibodies giving a perinuclear fluorescence and directed to a 200-kilodalton polypeptide of the nuclear envelope have been described in primary biliary cirrhosis. The purpose of this study, based on a series of 150 patients with primary biliary cirrhosis, was to ascertain the prevalence of these antibodies and to compare patients with and without these antibodies. Antinuclear antibodies giving a perinuclear fluorescence were demonstrated in 43 of the 150 patients (29%); antibodies directed to the 200-kilodalton polypeptide of the nuclear envelope were found in 40 of these 43 patients. Asthenia, arthralgia, associated extrahepatic diseases, Raynaud's phenomenon, and other antinuclear specificities were significantly less common, and titers of antimitochondrial antibodies were significantly lower in patients with antibodies directed to the 200-kilodalton polypeptide of the nuclear envelope than in patients without these antibodies. Clinical outcome, liver tests, and histological lesions did not significantly differ in patients with and without these antibodies.
Laboratoire d'Immunochimie et d'Immunopathologie (INSERM), Hôpital Saint-Louis, Paris, France.
K
K
Lassoued
R
R
Brenard
F
F
Degos
J C
JC
Courvalin
C
C
Andre
F
F
Danon
J C
JC
Brouet
Y
Y
Zine-el-Abidine
C
C
Degott
S
S
Zafrani
D000974:Antibodies, Antinuclear / Q000302:isolation & purification*; D000918:Antibody Specificity; D004247:DNA / Q000276:immunology; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D015151:Immunoblotting; D008105:Liver Cirrhosis, Biliary / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D009685:Nuclear Envelope / Q000276:immunology*
D000974:Antibodies, Antinuclear; D004247:DNA